Gemcitabine in combination with capecitabine compared with gemcitabine combined with erlotinib in locally advanced or metastatic pancreatic cancer

被引：0
|
作者：
Khatri, P. [1 ]
Kumari, P. [2 ]
Beniwal, S. [3 ]
Samdariya, S. [4 ]
机构：
[1] Acharya Tulsi Canc Hosp & Res Ctr & Allied Hosp, Bikaner, India
[2] Acharya Tulsi Reg Canc Treatment & Res Ctr, Bikaner, India
[3] ATRCTRI, Bikaner, India
[4] AIIMS Jodhpur, Jodhpur, Rajasthan, India
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RM-028
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [41] Comparison of the efficacy of gemcitabine with capecitabine and gemcitabine with erlotinib combination chemotherapy in recurrent or advanced pancreatic cancer as first-line treatment: Single-center experience
    Chun, S.
    Lee, M.
    Jeon, E.
    An, H.
    Hong, T.
    You, Y.
    Kim, D.
    Lee, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [42] Gemcitabine plus capecitabine is effective in advanced pancreatic cancer
    Nature Clinical Practice Oncology, 2007, 4 (9): : 504 - 504
  • [43] Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer
    Van Cutsem, Eric
    Vervenne, Walter L.
    Bennouna, Jaafar
    Humblet, Yves
    Gill, Sharlene
    Van Laethem, Jean-Luc
    Verslype, Chris
    Scheithauer, Werner
    Cosaert, Aijing Shang Jan
    Moore, Malcolm J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (13) : 2231 - 2237
  • [44] Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine Followed by Gemcitabine and Capecitabine/Radiation Therapy and Surgery in Locally Advanced, Unresectable Pancreatic Adenocarcinoma
    Sherman, William H.
    Chu, Kyung
    Chabot, John
    Allendorf, John
    Schrope, Beth Ann
    Hecht, Elizabeth
    Jin, Brian
    Leung, David
    Remotti, Helen
    Addeo, Gisella
    Postolov, Inna
    Tsai, Wei
    Fine, Robert L.
    CANCER, 2015, 121 (05) : 673 - 680
  • [45] Phase I study of combination of pasireotide LAR plus gemcitabine in locally advanced or metastatic pancreatic cancer
    Suleiman, Yaman
    Mahipal, Amit
    Shibata, David
    Siegel, Erin M.
    Jump, Helen
    Fulp, William J.
    Springett, Gregory M.
    Kim, Richard
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (03) : 481 - 487
  • [46] Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer
    Eun Kyoung Jeon
    Hye-Sung Won
    Yoon-Ho Ko
    In Seok Lee
    Tae Ho Hong
    Young Kyoung You
    Myung Ah Lee
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 1625 - 1630
  • [47] A phase 1/2 study of combination therapy of ivaltinostat, gemcitabine, and erlotinib in patients with unresectable, locally advanced and metastatic pancreatic adenocarcinoma
    Jo, J.
    Lee, H.
    Park, S.
    Chung, D.
    Cho, S.
    Cha, H.
    Cho, J.
    Song, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S211 - S211
  • [48] Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer
    Jeon, Eun Kyoung
    Won, Hye-Sung
    Ko, Yoon-Ho
    Lee, In Seok
    Hong, Tae Ho
    You, Young Kyoung
    Lee, Myung Ah
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (10) : 1625 - 1630
  • [49] Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis
    Wang, Yuan
    Hu, Guo-fang
    Zhang, Qian-qian
    Tang, Ning
    Guo, Jun
    Liu, Li-yan
    Han, Xiao
    Wang, Xia
    Wang, Zhe-hai
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 1961 - 1972
  • [50] Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer
    M. Ghosn
    A. Saroufim
    J. Kattan
    G. Chahine
    F. Nasr
    F. Farhat
    Medical Oncology, 2012, 29 : 2831 - 2837
12345